SCHEMBL20535645

SCHEMBL20535645

CC(CCC(=O)O)c1cccc(F)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGFR P43088 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.36
CTSA P10619 4/20 0.36
PPARG P37231 1/20 0.35
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34
GABRB2 P47870 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRE P78334 2/20 0.34
GABRA6 Q16445 2/20 0.34
GABRG1 Q8N1C3 2/20 0.34
GABRG3 Q99928 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27728236 0.84 CPA3 (0.45) SMN1; SMN2CYP1A2
SCHEMBL23717567 0.82 CYP1A2 (0.35) PTGFRSMN1; SMN2CYP1A2
SCHEMBL21631958 0.79 PTGFR (0.39) PTGFRSMN1; SMN2KDM4ECTSACYP1A2
SCHEMBL21631986 0.79 PTGFR (0.45) PTGFRCYP1A2
SCHEMBL20535701 0.79 FFAR4 (0.43) PTGFRSMN1; SMN2GABRPGABRDGABRA1
SCHEMBL20534568 0.79 KDM4E (0.42) PTGFRSMN1; SMN2KDM4EPPARG
SCHEMBL20534596 0.78 FFAR4 (0.41) PTGFRGABRPGABRDGABRA1GABRB1
SCHEMBL20280198 0.78 ADRB2 (0.42) CTSACYP1A2
SCHEMBL22871213 0.75 TSHR (0.47) KDM4EGABRA1GABRG2GABRB3CYP1A2
SCHEMBL19612568 0.73 CYP3A4 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609870-A1 SUBSTITUTED N-ARYLETHYL-2-AMINOQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189012-A1 SUBSTITUTED N-ARYLETHYL-2-AMINOQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed